News

The cardiac amyloidosis diagnostic algorithm should always begin with a monoclonal protein screen to assess for the presence of a plasma cell disorder and, therefore, supportive evidence for AL-CM ...
An artificial intelligence-guided algorithm to identify cardiac amyloidosis received a breakthrough device designation from the FDA. Earlier identification could improve care of patients with ...
A quiet revolution in care is helping patients with cardiac amyloidosis, a form of heart failure that long stumped doctors.
This time around, the FDA bestowed the label upon Anumana’s algorithm targeting cardiac amyloidosis, a condition in which abnormal tissues build up in and around the heart, making it more ...
The document provides a diagnostic algorithm and emphasizes the need for a multidisciplinary, individualized approach for this under-recognized cause of heart failure.
A new deep-learning algorithm can better identify subtle left ventricular (LV) wall geometric measurements on echocardiography than expert physicians, as validated on three international cohorts, a ...
The plan is to develop a new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis. As per the partnership, Anumana will conduct a clinical validation trial and pursue ...
Cardiac amyloidosis is a heart condition in which abnormal proteins build up in the heart muscle, making it stiff and impairing its ability to pump blood. Multiple life-prolonging drug treatments ...
Another name for this condition is cardiac amyloidosis. This article will discuss amyloid heart disease, including its symptoms, causes, diagnosis, risk factors, and treatment options.
I was constantly sweating." She was also retaining fluid. Elsie soon learned the cause - cardiac amyloidosis. "We used to think of it more as a rare disease," says Dr. Carly Fabrizio of Temple Health.
Anumana Inc. has garnered a U.S. FDA breakthrough device designation for its artificial intelligence (AI)-powered electrocardiogram-based algorithm for early identification of cardiac amyloidosis. The ...